% | $
Quotes you view appear here for quick access.

Jones Soda Co. (JSDA) Message Board

  • nuttierthansquirrellshiat nuttierthansquirrellshiat Jun 17, 2014 9:13 PM Flag


    sounds like you lost money on AFFY even though you never mentioneed you bought in and were holding...gonna throw another one at you ,,,it's a baby bio 250mm market cap ,, had a nice run up to PROOF OF CONCEPT results ,, the results were positive...but instituitional shorts pulled the rug out from under them on the good results ,,very little downside risk and a 3 bagger potential by the end of the year ...the science and fundamentals are strong for a baby bio .. check it out you might like it ..would recommend using options as the stock runs but only sell puts and calls ......TICKER...IDRA...

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • nuttierthansquirrellshiat nuttierthansquirrellshiat Jun 23, 2014 6:52 PM Flag

      6 days later ...article from the street...

      Another stock that's starting to trend within range of triggering a major breakout trade is Idera Pharmaceuticals (IDRA_), which is engaged in the discovery and development of novel therapeutics that modulate immune responses through toll-like receptors in the U.S. This stock has been hit hard by the bears so far in 2014, with shares off sharply by 33%.

      4 Stocks Breaking Out on Big Volume

      If you take a glance at the chart for Idera Pharmaceuticals, you'll notice that this stock has been uptrending a bit for the last month and change, with shares moving higher from its low of $2.34 to its recent high of $3.49 a share. During that uptrend, shares of IDRA have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of IDRA within range of triggering a major breakout trade above some key near-term overhead resistance levels.

      Traders should now look for long-biased trades in IDRA if it manages to break out above some near-term overhead resistance levels at $3.35 to $3.49 a share and then once it takes out more key resistance at $3.68 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 2.88 million shares. If that breakout materializes soon, then IDRA will set up to re-test or possibly take out its next major overhead resistance levels at $4.50 to $4.80 a share, or even $5.50 to $6 a share.

      Traders can look to buy IDRA off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $2.68 or at $2.30 a share. One can also buy IDRA off strength once it starts to bust above those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point. Less

    • nutty - IDRA has unfilled gap at 1. I would avoid it. One of my spec biotech plays is ANTH unfilled gap at 40 and Orbimed advisors has position. GLTA

0.40+0.0010(+0.34%)Oct 26 3:57 PMEDT